Literature DB >> 11443864

Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines.

C M Rooney1, L K Aguilar, M H Huls, M K Brenner, H E Heslop.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11443864     DOI： 10.1007/978-3-642-56515-1_14

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  13 in total

1.  Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Authors:  Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; Tontanai Numbenjapon; Jennifer Bennitt; Daniel Kim; David Smith; George McNamara; Zaid Al-Kadhimi; Joseph Rosenthal; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 2.  Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.

Authors:  Marco Ruella; Saad S Kenderian
Journal:  BioDrugs       Date:  2017-12       Impact factor: 5.807

Review 3.  Prospects of a novel vaccination strategy for human gamma-herpesviruses.

Authors:  Ting-Ting Wu; Marcia A Blackman; Ren Sun
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

4.  Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.

Authors:  Alexander Röth; Gabriela M Baerlocher; Mike Schertzer; Elizabeth Chavez; Ulrich Dührsen; Peter M Lansdorp
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

5.  Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.

Authors:  F Zhu; G Ramadan; B Davies; D A Margolis; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

Review 6.  Immunotherapy of malignant brain tumors.

Authors:  Duane A Mitchell; Peter E Fecci; John H Sampson
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

7.  Anti-human immunodeficiency virus-gag CD8+ memory T cells generated in vitro from Listeria-immunized mice.

Authors:  Marina Rayevskaya; Natasha Kushnir; Fred R Frankel
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

Review 8.  DNA vaccines to attack cancer.

Authors:  Freda K Stevenson; Christian H Ottensmeier; Peter Johnson; Delin Zhu; Sarah L Buchan; Katy J McCann; Joanne S Roddick; Andrew T King; Feargal McNicholl; Natalia Savelyeva; Jason Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

9.  Gene Therapy Applications to Cancer Treatment.

Authors:  Susy M. Scholl; Silke Michaelis; Ray McDermott
Journal:  J Biomed Biotechnol       Date:  2003

Review 10.  Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target.

Authors:  Christian Münz
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.